Eckert & Ziegler Officially Requests Special IBt Shareholder Meeting

BERLIN, January 8 - Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN
DE0005659700) has officially instructed the statutory auditor of publicly
listed Belgian seed manufacturer International Brachytherapy S.A. (IBt) to
convene, as quickly as feasible, a special general meeting of the
shareholders of IBt. Sole item on the agenda is the replacement of IBt
non-executive board member H&H Capital Management BVBA, represented by its
sole director and Creafund representative Herman Wielfaert, by a
representative of Steglitz Medinvest UG (SMI), who together with Eckert &
Ziegler on 28 December 2009 initiated a public take-over bid for IBt. SMI,
which holds about 22% of the shares in IBt, has so far not been represented
on IBt's board at all.

"SMI is a party to the take-over bid and a large IBt
shareholder, so it is natural that it should also nominate at least one
member of the IBt board", explains Andreas Eckert, CEO of Eckert & Ziegler.
"Creafund, on the other hand, has spent considerable effort and money in
suing Eckert & Ziegler and SMI for a cash offer for IBt shares. Now that we
have voluntarily, and at a substantial effort, complied with Creafund's
wishes, we would in any way expect that Creafund accepts the offer and
vacates his board seat."

Eckert & Ziegler currently owns about 29% of the shares of IBt
and is represented on the board by two non executive directors. Four other
directors of the board are independent. Three are Executive Directors that
compose the management team. Together with the SMI representative the new
board would have ten directors, the maximum amount of incumbents allowed by
IBt's articles of association.

Contact:

Eckert & Ziegler AG, Karolin Riehle, Investor Relations,
Robert-Rössle-Str. 10, 13125 Berlin, Tel: +49(0)30-94-10-84-138,
Fax: +49(0)30-94-10-84-112, E-Mail:karolin.riehle@ezag.de

www.ezag.de

Contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str. 10, 13125 Berlin, Tel: +49(0)30-94-10-84-138, Fax: +49(0)30-94-10-84-112, E-Mail:karolin.riehle at ezag.de